← Eichor
Study identifier: NCT07237685 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Evaluating Atherosclerotic Disease Progression in Patients With Diabetes Mellitus

Condition: Type 2 Diabetes · Coronary Artery Disease (CAD) · Atherosclerosis Cardiovascular Disease  ·  Sponsor: Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)

PhaseN/A
Planned participants1000
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

People with type 2 diabetes have a much higher risk of heart disease. One common problem is when the blood vessels that supply the heart become narrowed or blocked by fatty deposits, called plaque. This makes it harder for blood to reach the heart and can lead to serious problems such as chest pain, heart attacks, or even death. This study will follow people with type 2 diabetes who have already had a special heart scan called a coronary CT angiography. This scan takes detailed pictures of the heart's blood vessels. The goal is to understand how heart disease changes over time in people with type 2 diabetes, by looking at repeat scans and other health information. By learning more about how plaque builds up or gets worse, researchers hope to find better ways to identify which patients are most at risk for future heart problems.

This description comes directly from the study's public registry record.

Talk to the study team

Willem R van de Vijver, MD  ·  +31205662402  ·  w.r.vandevijver@amsterdamumc.nl

Always discuss trial participation with your own doctor first.

Locations (2)

Amsterdam University Medical CentersAmsterdam, NetherlandsNot Yet Recruiting
Cardiology Centers of the NetherlandsAmsterdam, NetherlandsRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07237685